Non-Complying Goods Sample Clauses

Non-Complying Goods. Seller shall be responsible for all risk and expenses, including transportation charges, associated with (a) the return of all Non- Complying Goods (as defined in section 6.1 below), over shipments, and early shipments returned by AGILENT to Seller; and (b) the shipment to AGILENT by Seller of all repaired, replacement and reworked Goods.
Non-Complying Goods. Only Goods that have been determined and tested for quantity and conditions by Xxxxxxx’s Incoming Inspection Department will be considered officially delivered and relevant for invoicing. Seller shall be responsible for all risk and expenses, including transportation charges, associated with (a) the return of all Non-Complying Goods (as defined in section 6.1 below), over shipments, and early shipments returned by AGILENT to Seller; and (b) the shipment to AGILENT by Seller of all repaired, replacement and reworked Goods.
Non-Complying Goods. (a) Without limiting any other rights or remedies the Company may have, if there is a Fault in all or part of the Goods (“Non- Complying Goods”), the Company may, irrespective of whether it has paid for the Non-Complying Goods or not, reject the Non-Complying Goods. (b) If the Company rejects the Non-Complying Goods under clause 4.3(a), the Company may require the Supplier to at the Supplier’s cost and at the Company's option: (i) collect and replace the Non-Complying Goods; (ii) collect and repair the Non-Complying Goods; or (iii) collect the Non-Complying Goods, and refund to the Company all payments made by the Company to the Supplier for the Non-Complying Goods and any compensation reasonably required by the Company for the replacement of the Non-Complying Goods by another supplier, within 2 Business Days of the Company’s request.
Non-Complying Goods. Seller shall be responsible for all risk and expenses, including transportation charges, associated with (a) the return of all Non-complying Goods, over shipments and early shipments returned by Esco to seller; and (b) the shipment to Esco by Seller of all repaired, replacement and reworked Goods.
Non-Complying Goods. Seller shall be responsible for all risk and expenses, including transportation charges, associated with (a) the return of all Non- Complying Goods (as defined in section 6.1 below), over shipments, and early shipments returned by AGILENT to Seller; and (b) the shipment to AGILENT by Seller of all repaired, replacement and reworked Goods. or cancel any portion of this Order, provided AGILENT gives Seller notice (a) for customized Goods or Services (i.e., supplied exclusively in accordance with AGILENT's designs or specifications), at least thirty (30) calendar days prior to the Delivery Date; and (b) for all other Goods or Services at any time prior to shipment.
Non-Complying Goods. 12.1 The Supplier must give BOPDHB written notice immediately if it: a. is required by Law to recall or modify all or any of the Goods; or b. becomes aware of any non-compliance that affects or has the potential to affect the safety of all or any of the Goods. 12.2 If any of the events referred to clause 12.1 occur, the Supplier shall: a. consult with XXXXXX; and b. if required by BOPDHB, use its best endeavours to provide replacement Goods to BOPDHB as soon as possible. 12.3 Notwithstanding clause 12.2, BOPDHB reserves its rights to purchase alternative goods elsewhere in accordance with clause 39 (failure to comply).
Non-Complying Goods. Where any of part of the Goods is not in accordance with this Contract or the reasonable directions of the Principal, or the Contractor fails to comply with any obligations of the Contractor under the Contract, then the Principal may in its absolute discretion by notice in writing to the Contractor: (a) accept the non-conforming Goods in which case the Price of such Goods will be adjusted as if the Principal had directed a Variation for the non-conformance; (b) reject the whole of the Goods or the non-conforming part and direct the Contractor to refund all monies paid for the rejected Goods; (c) direct the Contractor to: (i) remove, replace or repair the non-conforming Goods or otherwise make the non-conforming Goods compliant with the Contract; and (ii) make good any resultant damage to any other property or work, at the Contractor's expense and within the time directed by the Principal or may take such steps itself without first providing the Contractor with an opportunity to do so;
Non-Complying Goods. Supplier shall be responsible for all risk and expenses, including transportation charges, associated with (a) the return of all Non-Complying Goods (as defined in section 7.1 below), over shipments, and early shipments returned by BRIDGELUX to Supplier; and (b) the shipment to BRIDGELUX by Supplier of all repaired, replacement and reworked Goods.

Related to Non-Complying Goods

  • Clinical Data and Regulatory Compliance The preclinical tests and clinical trials, and other studies (collectively, “studies”) that are described in, or the results of which are referred to in, the Registration Statement or the Prospectus were and, if still pending, are being conducted in all material respects in accordance with the protocols, procedures and controls designed and approved for such studies and with standard medical and scientific research procedures; each description of the results of such studies is accurate and complete in all material respects and fairly presents the data derived from such studies, and the Company and its subsidiaries have no knowledge of any other studies the results of which are inconsistent with, or otherwise call into question, the results described or referred to in the Registration Statement or the Prospectus; the Company and its subsidiaries have made all such filings and obtained all such approvals as may be required by the Food and Drug Administration of the U.S. Department of Health and Human Services or any committee thereof or from any other U.S. or foreign government or drug or medical device regulatory agency, or health care facility Institutional Review Board (collectively, the “Regulatory Agencies”); neither the Company nor any of its subsidiaries has received any notice of, or correspondence from, any Regulatory Agency requiring the termination, suspension or modification of any clinical trials that are described or referred to in the Registration Statement or the Prospectus; and the Company and its subsidiaries have each operated and currently are in compliance in all material respects with all applicable rules, regulations and policies of the Regulatory Agencies.